Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 24-Nov-25 | 10069.00 | 0.69% | - | 1.04% | 155/229 |
| 1 Month | 31-Oct-25 | 10019.60 | 0.20% | - | 0.42% | 121/229 |
| 3 Month | 01-Sep-25 | 10313.10 | 3.13% | - | 4.22% | 138/226 |
| 6 Month | 30-May-25 | 10591.30 | 5.91% | - | 6.29% | 108/215 |
| YTD | 01-Jan-25 | 10039.30 | 0.39% | - | 5.70% | 142/201 |
| Since Inception | 06-Dec-24 | 10210.00 | 2.10% | 2.13% | 14.13% | 179/201 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 116.5 | 10.89% | -1.37% | 13.47% (Dec 2024) | 0% (Nov 2024) | 68.89 k | -0.12 L |
| Divis Laboratories Ltd. | Pharmaceuticals | 105 | 9.82% | 1.42% | 9.82% (Oct 2025) | 0% (Nov 2024) | 15.59 k | 110.00 |
| Max Healthcare Institute Ltd. | Hospital | 75.9 | 7.10% | -0.30% | 7.94% (Jun 2025) | 0% (Nov 2024) | 66.11 k | -3.48 k |
| Aster DM Healthcare Ltd. | Hospital | 67.9 | 6.35% | 0.26% | 6.35% (Oct 2025) | 0% (Nov 2024) | 1.00 L | -1.77 k |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 59.1 | 5.53% | -0.88% | 6.52% (Dec 2024) | 0% (Nov 2024) | 49.36 k | -5.53 k |
| Mankind Pharma Ltd. | Pharmaceuticals | 50.9 | 4.76% | -0.46% | 5.22% (Sep 2025) | 0% (Nov 2024) | 21.34 k | -1.11 k |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 48.4 | 4.53% | -0.17% | 4.7% (Sep 2025) | 0% (Nov 2024) | 28.79 k | 0.00 |
| # Rubicon Research Ltd. | Pharmaceuticals | 41.4 | 3.87% | 3.87% | 3.87% (Oct 2025) | 0% (Nov 2024) | 66.96 k | 66.96 k |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 39.5 | 3.69% | -0.22% | 3.95% (Aug 2025) | 0% (Nov 2024) | 54.76 k | -3.82 k |
| Ajanta Pharma Limited | Pharmaceuticals | 37.6 | 3.52% | 0.25% | 3.52% (Oct 2025) | 0% (Nov 2024) | 15.26 k | 1.02 k |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.48% |
| Net Receivables | Net Receivables | 1.02% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 24 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 3 is/are ranked 4 * , 3 is/are ranked 3 * , 4 is/are ranked 2 * , 2 is/are ranked 1 * , and 11 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| PGIM India Midcap Fund - Direct Plan - Growth | 2 | 11580.71 | -0.26 | -0.39 | 4.92 | 5.07 | 14.04 |
| PGIM India Flexi Cap Fund - Direct Plan - Growth | 2 | 6399.39 | 0.53 | 3.15 | 6.76 | 7.80 | 13.84 |
| PGIM India Global Equity Opportunities Fund of Fund - Direct Plan - Growth | NA | 1661.69 | -2.65 | 4.58 | 13.63 | 9.76 | 22.51 |
| PGIM India Small Cap Fund - Direct Plan - Growth | 3 | 1633.93 | -1.84 | 0.80 | 6.68 | 2.14 | 14.57 |
| PGIM India Balanced Advantage Fund - Direct Plan - Growth | NA | 953.20 | 1.07 | 3.33 | 4.72 | 7.72 | 11.47 |
| PGIM India Emerging Markets Equity Fund of Fund - Direct Plan - Growth | NA | 875.49 | -2.33 | 3.01 | 16.29 | 19.87 | 16.48 |
| PGIM India Large and Midcap Fund - Direct Plan - Growth | NA | 802.79 | 0.38 | 2.18 | 5.47 | 8.48 | 0.00 |
| PGIM India ELSS Tax Saver Fund - Direct Plan - Growth | 2 | 782.13 | 0.66 | 3.05 | 4.63 | 6.03 | 13.32 |
| PGIM India Large Cap Fund - Direct Plan - Growth | 3 | 608.98 | 1.62 | 4.88 | 6.57 | 9.25 | 12.74 |
| PGIM India Liquid Fund - Direct Plan - Growth | 1 | 573.44 | 0.48 | 1.46 | 2.97 | 6.73 | 7.10 |